Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda

dc.contributor.authorAlibhai, Arif
dc.contributor.authorKipp, Walter
dc.contributor.authorSenthilselvan, Ambikaipakan
dc.contributor.authorKonde-Lule, Joseph
dc.contributor.authorOkech-Ojony, Joa
dc.contributor.authorRubaale, Tom
dc.date.accessioned2023-04-20T11:40:36Z
dc.date.available2023-04-20T11:40:36Z
dc.date.issued2010
dc.description.abstractThe purpose of this study was to examine gender differences in mortality for human immunodeficiency virus (HIV) patients in rural Western Uganda after six months of highly active antiretroviral therapy (HAART). Three hundred eighty five patients were followed up for six months after initiating HAART. Statistical analysis included descriptive, univariate and multivariate methods, using Kaplan–Meier estimates of survival distribution and Cox proportional hazards regression. Mortality in female patients (9.0%) was lower than mortality in males (13.5%), with the difference being almost statistically significant (adjusted hazard ratio for females 0.55; 95% confidence interval [CI]: 0.28–1.07; P = 0.08). At baseline, female patients had a significantly higher CD4+ cell count than male patients (median 147 cells/μL vs 120 cells/μL; P < 0.01). A higher CD4+ cell count and primary level education were strongly associated with better survival. The higher CD4+ cell count in females may indicate that they accessed HAART services at an earlier stage of their disease progression than males. A borderline statistically significant lower mortality rate in females shows that females fare better on treatment in this context than males. The association between lower mortality and higher CD4+ levels suggest that males are not accessing treatment early enough and that more concerted efforts need to be made by HAART programs to reach male HIV patients.en_US
dc.identifier.citationAlibhai, A., Kipp, W., Saunders, L. D., Senthilselvan, A., Kaler, A., Houston, S., ... & Rubaale, T. (2010). Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. International journal of women's health, 45-52.https://doi.org/10.2147/ijwh.s9408en_US
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/8542
dc.language.isoenen_US
dc.publisherInternational journal of women's healthen_US
dc.subjectantiretroviral treatmenten_US
dc.subjectgenderen_US
dc.subjectruralen_US
dc.titleGender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Gender related mortality for HIV infected patients on highly active antiretroviral therapy HAART in rural Uganda.pdf
Size:
411.33 KB
Format:
Adobe Portable Document Format
Description:
Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: